Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.54 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 6/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.51 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3441192 | 0.84 | HSPD1 (0.60) | HSPD1HSPE1MEN1KMT2ALMNA | |
| SCHEMBL28091035 | 0.84 | GPR27 (0.57) | MEN1KMT2ALMNATP53HPGD | |
| SCHEMBL766990 | 0.81 | HSPD1 (0.57) | HSPD1HSPE1MEN1KMT2ALMNA | |
| SCHEMBL2169634 | 0.81 | MEN1 (0.68) | HSPD1HSPE1MEN1KMT2ALMNA | |
| SCHEMBL5852388 | 0.79 | KLKB1 (0.72) | MEN1KMT2ALMNATP53HPGD | |
| SCHEMBL27754113 | 0.77 | KMT2A (0.61) | MEN1KMT2ALMNATP53HPGD | |
| SCHEMBL229763 | 0.76 | HSPD1 (0.68) | HSPD1HSPE1MEN1KMT2ALMNA | |
| SCHEMBL29474808 | 0.76 | HSPD1 (0.68) | HSPD1HSPE1MEN1KMT2ALMNA | |
| SCHEMBL7067826 | 0.76 | MEN1 (0.71) | HSPD1HSPE1MEN1KMT2ALMNA | |
| SCHEMBL8052698 | 0.76 | KMT2A (0.69) | HSPD1HSPE1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| WO-2024064209-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| WO-2022040799-A1 | ANTIMICROBIAL COMPOSITION | GP TECH INOVASYON TEKNOLOJI VE ARASTIRMA A.S (TR) | 2022-03-03 | — | — | WO | claimed |
| EP-3927334-A1 | NONHORMONAL UNISEX CONTRACEPTIVES | The Regents of The University of California (US) | 2021-12-29 | — | — | EP | claimed |
| US-20210369652-A1 | Nonhormonal Unisex Contraceptives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-02 | — | — | US | claimed |
| US-11166926-B2 | Compositions and methods for protecting a host from enteric toxigenic pathogens | THE HOSPITAL FOR SICK CHILDREN (CA) | 2021-11-09 | — | — | US | claimed |
| CN-113453673-A | Non-hormone contraceptive for both men and women | 加利福尼亚大学董事会 | 2021-09-28 | — | — | CN | claimed |
| US-20090215888-A1 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2009-08-27 | — | — | US | claimed |
| WO-2007098591-A2 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2007-09-07 | — | — | WO | claimed |
| US-7198800-B1 | Compositions and methods | Ko, Thomas Sai Ying (CN) | 2007-04-03 | — | — | US | claimed |
| EP-1696855-A1 | DERMAL DRUG DELIVERY SYSTEM | Medpharm Limited (GB) | 2006-09-06 | — | — | EP | claimed |
| US-20060130266-A1 | Dermal drug delivery system | MEDPHARM LIMITED (GB) | 2006-06-22 | — | — | US | claimed |
| WO-2005058226-A1 | DERMAL DRUG DELIVERY SYSTEM | MEDPHARM LIMITED (GB) | 2005-06-30 | — | — | WO | claimed |
| JP-2003514875-A | — | — | 2003-04-22 | — | — | JP | claimed |
| EP-1231948-A1 | A PROPELLANT FREE SPRAY-ON SKIN PATCH COMPOSITION FOR IMPROVING WOUND HEALING AND FOR DRUG ADMINISTRATION | Ever Power Holding Inc. (VG) | 2002-08-21 | — | — | EP | claimed |
| WO-2001037890-A1 | A PROPELLANT FREE SPRAY-ON SKIN PATCH COMPOSITION FOR IMPROVING WOUND HEALING AND FOR DRUG ADMINISTRATION | EVER POWER HOLDING INC (VG) | 2001-05-31 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | AHCY, MACO1, ME3 | HSPD1 1087/4885HSPE1 1950/4885MEN1 2966/4885 |
| US-20210369652-A1 | Nonhormonal Unisex Contraceptives | UQCRC1, UQCRC2, MCU | HSPD1 90/4885HSPE1 58/4885MEN1 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.